Target site pharmacokinetics of linezolid after single and multiple doses in diabetes patients with soft tissue infection.

Trial Profile

Target site pharmacokinetics of linezolid after single and multiple doses in diabetes patients with soft tissue infection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 May 2015

At a glance

  • Drugs Linezolid (Primary)
  • Indications Bacterial infections; Soft tissue infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 May 2015 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 12 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top